Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases

NCT00557557 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Liver Metastases

Interventions

DRUG: Drug: 5-FU
DRUG: Drug: Oxaliplatin

Sponsor

David Bartlett

Collaborators

[object Object]
[object Object]